PEGylated Proteins Market
Market Research Report I 2024-04-29 I 74 Pages I BCC Research
Description
Report Scope
This report highlights the current and future market potential of PEGylated proteins and provides a detailed analysis of the drivers, restraints, and opportunities in this market. The report also surveys the competitive environment for PEGylated proteins, including coverage of the pipeline activities adopted by players in this market, and it includes market projections for 2028. Also included are company profiles of key players featuring detailed information about each company's business segments, financials, product portfolios and recent developments. The report does not cover PEGylated vaccines.
In this report, the global market for PEGylated proteins market is segmented into four regions: North America, Europe, Asia-Pacific and Rest of the World. For market estimates, data is provided for 2020 and 2021 (which serve as the historic years), for 2022 (the base year), and forecast for 2028.
Report Includes
- 41 data tables and 22 additional tables
- Analysis of the PEGylated proteins market
- Analyses of global market trends, with revenue data for 2021-2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2028
- Estimates of the current market size and revenue growth prospects, along with a market share analysis by product and services, protein type, application, and region
- Facts and figures pertaining to the market drivers, opportunities and restraints, and the impact of macroeconomic variables
- An analysis of recent patent grants and published patents
- A look at emerging technologies and regulatory issues
- Overview of sustainability trends and ESG developments, including consumer attitudes, companies' ESG score rankings and their ESG practices
- Insight into the competitive landscape, including companies' market shares, business segments, financials and product portfolios, as well as recent M&A activity and venture funding outlook
- Profiles of the major market players
Executive Summary
Summary:
The global market for PEGylated proteins is expected to grow from $10.2 billion in 2023 and projected to reach $15.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2023 to 2028.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Introduction
Advantages of Protein PEGylation
Limitations of PEGylated Therapeutics
Chapter 3 Market Dynamics
Market Dynamics Snapshot
Market Drivers
Protein Drugs in Hematology and Oncology
Design of Biobetters
Market Restraints
Immunogenicity and Side Effects
Formulation Challenges
Market Opportunities
Site-Specific PEGylation
New Indications and Formulation Techniques
Chapter 4 Emerging Technologies and Developments
Introduction
Non-Covalent PEGylation
PEGylation of Nanoparticles
Antibody-Drug Conjugates (ADCs)
Chapter 5 Market Segmentation Analysis
Segmentation Breakdown
Global PEGylated Proteins Market, by Protein Type
Granulocyte-Colony Stimulating Factors (G-CSF)
PEGylated Monoclonal Antibodies
PEGylated Interferons
PEGylated Recombinant Factors
Other Protein Types
Global PEGylated Proteins Market, by PEGylation Type
Linear PEGylated Proteins
Branched PEGylated Proteins
Global PEGylated Proteins Market, by PEGylation Application
Autoimmune Diseases
Hematology
Cancer
Other Applications
Geographic Breakdown
Global Market for PEGylated Proteins, by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 6 Competitive Intelligence
Recent Developments in the PEGylated Proteins Market
Clinical Trial Activities
Chapter 7 Sustainability in the PEGylated Proteins Market: ESG Perspective
Introduction
Sustainability in the PEGylated Proteins Industry
Understanding the ESG Data
Environmental Performance
Social Performance
Governance Performance
Concluding Remarks from BCC
Chapter 8 Appendix
Methodology
Sources
Abbreviations
Company Profiles
AMGEN INC.
F. HOFFMANN-LA ROCHE LTD.
MERCK KGAA
PFIZER INC.
SANDOZ GROUP AG
List of Tables
Summary Table : Global Market for PEGylated Proteins, by Region, Through 2028
Table 1 : PEGylated Drugs in Clinical Trials for Cancer
Table 2 : Discontinued PEGylated Drugs in Clinical Trials
Table 3 : Side Effects Observed with Approved Products
Table 4 : Global Market for PEGylated Proteins, by Protein Type, Through 2028
Table 5 : Marketed PEGylated G-CSF Drugs
Table 6 : Global Market for G-CSF, by Region, Through 2028
Table 7 : Global Market for PEGylated mAbs, by Region, Through 2028
Table 8 : Global Market for PEGylated Interferons, by Region, Through 2028
Table 9 : Global Market for PEGylated Recombinant Factors, by Region, Through 2028
Table 10 : Global Market for Other Protein Types, by Region, Through 2028
Table 11 : Global Market for PEGylated Proteins, by PEGylation Type, Through 2028
Table 12 : Global Market for Linear PEGylated Proteins, by Region, Through 2028
Table 13 : Global Market for Branched PEGylated Proteins, by Region, Through 2028
Table 14 : Global Market for PEGylated Proteins, by Application, Through 2028
Table 15 : Global Market for PEGylated Proteins for Autoimmune Diseases, by Region, Through 2028
Table 16 : Global Market for PEGylated Proteins for Hematology, by Region, Through 2028
Table 17 : Global Market for PEGylated Proteins for Cancer, by Region, Through 2028
Table 18 : Global Market for PEGylated Proteins for Other Applications, by Region, Through 2028
Table 19 : Global Market for PEGylated Proteins, by Region, Through 2028
Table 20 : North American Market for PEGylated Proteins, by Country, Through 2028
Table 21 : North American Market for PEGylated Proteins, by Protein Type, Through 2028
Table 22 : North American Market for PEGylated Proteins, by PEGylation Type, Through 2028
Table 23 : North American Market for PEGylated Proteins, by Application, Through 2028
Table 24 : European Market for PEGylated Proteins, by Country, Through 2028
Table 25 : European Market for PEGylated Proteins, by Protein Type, Through 2028
Table 26 : European Market for PEGylated Proteins, by PEGylation Type, Through 2028
Table 27 : European Market for PEGylated Proteins, by Application, Through 2028
Table 28 : Asia-Pacific Market for PEGylated Proteins, by Country, Through 2028
Table 29 : Asia-Pacific Market for PEGylated Proteins, by Protein Type, Through 2028
Table 30 : Asia-Pacific Market for PEGylated Proteins, by PEGylation Type, Through 2028
Table 31 : Asia-Pacific Market for PEGylated Proteins, by Application, Through 2028
Table 32 : RoW Market for PEGylated Proteins, by Protein Type, Through 2028
Table 33 : RoW Market for PEGylated Proteins, by PEGylation Type, Through 2028
Table 34 : RoW Market for PEGylated Proteins, by Application, Through 2028
Table 35 : Recent Developments in PEGylated Proteins Market, 2022 and 2023
Table 36 : Competitor Clinical Trial Activities in PEGylated Protein Therapeutics, by Phase, 2023
Table 37 : ESG Risk Rankings for Major PEGylated Protein Drug Companies*
Table 38 : ESG: Environmental Overview
Table 39 : ESG: Social Overview
Table 40 : ESG: Governance Overview
Table 41 : Report Sources
Table 42 : Abbreviations Used in this Report
Table 43 : Amgen Inc.: Company Snapshot
Table 44 : Amgen Inc.: Financial Performance, FY 2022 and 2023
Table 45 : Amgen Inc.: Product Portfolio
Table 46 : Amgen Inc.: News/Key Developments, 2023
Table 47 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 48 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 49 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 50 : Merck KGaA: Company Snapshot
Table 51 : Merck KGaA: Financial Performance, FY 2022 and 2023
Table 52 : Merck KGaA: Product Portfolio
Table 53 : Merck KGaA: News/Key Developments, 2022 and 2023
Table 54 : Pfizer Inc.: Company Snapshot
Table 55 : Pfizer Inc.: Financial Performance, FY 2022 and 2023
Table 56 : Pfizer Inc.: Product Portfolio
Table 57 : Pfizer Inc.: News/Key Developments, 2023
Table 58 : Sandoz Group AG: Company Snapshot
Table 59 : Sandoz Group AG: Financial Performance, FY 2022 and 2023
Table 60 : Sandoz Group AG: Product Portfolio
Table 61 : Sandoz Group AG: News/Key Developments, 2023
List of Figures
Summary Figure : Global Market for PEGylated Proteins, by Region, 2020-2028
Figure 1 : Advantages of Protein PEGylation
Figure 2 : Timeline of PEGylated Protein Therapeutics
Figure 3 : Disadvantages of PEGylated Protein Therapeutics
Figure 4 : Market Dynamics of Global PEGylated Proteins
Figure 5 : Emerging Technologies in the PEGylated Proteins Market
Figure 6 : Global Market Shares of PEGylated Proteins, by Protein Type, 2022
Figure 7 : Global Market for G-CSF, by Region, 2020-2028
Figure 8 : Global Market for PEGylated mAbs, by Region, 2020-2028
Figure 9 : Global Market for PEGylated Interferons, by Region, 2020-2028
Figure 10 : Global Market for PEGylated Recombinant Factors, by Region, 2020-2028
Figure 11 : Global Market for Other Protein Types, by Region, 2020-2028
Figure 12 : Global Market Shares of PEGylated Proteins, by PEGylation Type, 2022
Figure 13 : Global Market for Linear PEGylated Proteins, 2020-2028
Figure 14 : Global Market for Linear PEGylated Proteins, by Region, 2020-2028
Figure 15 : Global Market for Branched PEGylated Proteins, 2020-2028
Figure 16 : Global Market for Branched PEGylated Proteins, by Region, 2020-2028
Figure 17 : Global Market Shares of PEGylated Proteins, by Application, 2022
Figure 18 : Global Market for PEGylated Proteins for Autoimmune Diseases, 2020-2028
Figure 19 : Global Market for PEGylated Proteins for Autoimmune Diseases, by Region, 2020-2028
Figure 20 : Global Market for PEGylated Proteins for Hematology, 2020-2028
Figure 21 : Global Market for PEGylated Proteins for Hematology, by Region, 2020-2028
Figure 22 : Global Market for PEGylated Proteins for Cancer, 2020-2028
Figure 23 : Global Market for PEGylated Proteins for Cancer, by Region, 2020-2028
Figure 24 : Global Market for PEGylated Proteins for Other Applications, 2020-2028
Figure 25 : Global Market for PEGylated Proteins for Other Applications, by Region, 2020-2028
Figure 26 : Global Market Shares of PEGylated Proteins, by Region, 2022
Figure 27 : Global Market for PEGylated Proteins, by Region, 2020-2028
Figure 28 : North American Market Shares of PEGylated Proteins, by Country, 2022
Figure 29 : European Market Shares of PEGylated Proteins, by Country, 2022
Figure 30 : Asia-Pacific Market Shares of PEGylated Proteins, by Country, 2022
Figure 31 : Snapshot of ESG Pillars
Figure 32 : Advantages of ESG for Companies
Figure 33 : Amgen Inc.: Revenue Share, by Country/Region, FY 2023
Figure 34 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 35 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 36 : Merck KGaA: Revenue Share, by Business Unit, FY 2023
Figure 37 : Merck KGaA: Revenue Share, by Country/Region, FY 2023
Figure 38 : Pfizer Inc.: Revenue Share, by Business Unit, FY 2023
Figure 39 : Pfizer Inc.: Revenue Share, by Country/Region, FY 2023
Figure 40 : Sandoz Group AG: Revenue Share, by Business Unit, FY 2023
Figure 41 : Sandoz Group AG: Revenue Share, by Country/Region, FY 2023
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.